InMode Ltd. (NASDAQ:INMD - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $17.40, but opened at $15.70. InMode shares last traded at $16.08, with a volume of 638,963 shares traded.
Analyst Ratings Changes
Several research analysts recently weighed in on the company. BTIG Research began coverage on InMode in a research note on Thursday, October 17th. They set a "buy" rating and a $25.00 target price for the company. Barclays reduced their price objective on shares of InMode from $29.00 to $27.00 and set an "overweight" rating for the company in a research report on Monday, October 14th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of InMode in a report on Thursday, October 31st. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $22.60.
Check Out Our Latest Stock Report on InMode
InMode Stock Performance
The stock has a 50 day moving average of $18.14 and a two-hundred day moving average of $17.33. The stock has a market cap of $1.34 billion, a PE ratio of 8.65 and a beta of 2.12.
Institutional Trading of InMode
A number of hedge funds have recently modified their holdings of the business. Doma Perpetual Capital Management LLC increased its stake in InMode by 210.7% in the 2nd quarter. Doma Perpetual Capital Management LLC now owns 2,011,240 shares of the healthcare company's stock valued at $36,685,000 after buying an additional 1,363,841 shares during the period. Federated Hermes Inc. increased its stake in shares of InMode by 191.9% in the second quarter. Federated Hermes Inc. now owns 1,125,017 shares of the healthcare company's stock worth $20,520,000 after acquiring an additional 739,629 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of InMode by 63.6% during the second quarter. Acadian Asset Management LLC now owns 1,124,887 shares of the healthcare company's stock worth $20,502,000 after acquiring an additional 437,122 shares in the last quarter. Lombard Odier Asset Management Europe Ltd acquired a new stake in InMode during the second quarter valued at $4,104,000. Finally, Systematic Financial Management LP increased its position in InMode by 34.5% in the 2nd quarter. Systematic Financial Management LP now owns 866,619 shares of the healthcare company's stock worth $15,807,000 after purchasing an additional 222,532 shares during the last quarter. Hedge funds and other institutional investors own 68.04% of the company's stock.
About InMode
(
Get Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Further Reading
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
